Form 4 Tracker
James Dean Watson

Director · 1 filing · Latest: Jul 23, 2026

Scribe Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing